Holly Goodson, Professor and Associate Chair of the Department of Chemistry &…

Sintim brings a wealth of expertise in both basic science and entrepreneurship to his new role.  

Rosenbaum and his collaborators published a new paper in Nature titled “Functional connectomics reveals general wiring rule in mouse visual cortex” (…

Ell Handy, a postdoctoral researcher at the University of Notre Dame with the Bioengineering Life Sciences Initiative (BELS), seeks to uncover new ways to diagnose and treat endometriosis,…

Graduate students from the University of Notre Dame joined peers from across Indiana at the Statehouse for the 2025 Indiana Science Communication Day, an event aimed at encouraging doctoral students to apply their research on a broader scale and bridging the gap between researchers and policymakers.…

Notre Dame researchers are advancing rare disease research and patient advocacy, driving groundbreaking discoveries to bring hope to patients and families. …

Notre Dame’s Bioengineering & Life Sciences Initiative has announced significant investments aimed at enhancing and growing biomedical research at the University. These include funding of four new cross-disciplinary faculty research teams and a milestone instrument…

Human Cytomegalovirus (CMV) is a virus found in more than 70% of the population in the United States. The virus remains dormant in healthy people. But for those with a weakened immune system, CMV can cause severe illness and death. CMV is the primary focus of Pilar Pérez Romero, associate...

Tengfei Luo and Matthew J. Webber have been named Senior Members by the National Academy of Inventors (NAI), making them the first Notre Dame faculty members to receive this honor.

A leading evolutionary hypothesis puts the RNA molecule—a messenger of genetic information and a builder of proteins—at the center of early life.

The lymphatic system plays a vital role in many health issues, such as heart disease, neurodegenerative conditions, inflammation, metabolic disorders, cancer, and lymphedema. Despite its importance, scientists still lack many details about how the lymphatic system grows and functions, and this prohibits…

This research identifies appropriate pathways to investigate for therapeutic targeting of pHi in cancer and neurodegeneration, opening the door for more effective disease treatment.

Herman Sintim Herman Sintim will join the Department of Chemistry and Biochemistry at the University of Notre Dame as…

Rare disease research can be as uncommon as the diseases themselves, but Notre Dame is committed to understanding, treating, and advocating for those affected by rare diseases. Read…

The Atlas of Inspiring Hispanic and Latinx Scientists, a database from the Fred Hutchinson Cancer Research Center that features Hispanic and Latinx scientific…

Today, the FDA announced the first approved treatment for Niemann-Pick Type C (NPC) disease: an oral medication named Miplyffa (arimoclomol). Sean Kassen, director of the Ara Parseghian Medical Research Fund at the University of Notre Dame, said this represents the beginning of a new and hopeful era for NPC families.

During the 2024 fiscal year, researchers at the University of Notre Dame submitted 1,310 proposals for external research funding for a total amount of $1.016 billion — the first time the University has surpassed the billion-dollar mark for proposals. In addition, the University received 829 separate awards — the largest...

Michael Levitt Nobel laureate Michael Levitt, a professor of structural…

Researchers from the University of Notre Dame are adding new evidence to the emerging concept that "silent" or synonymous mutations may have crucial consequences. Their study, published in the Proceedings of the National Academy of Sciences, showed how a synonymous mutation in one gene can significantly affect a neighboring gene,...

In work recently published in Nature Chemical Biology, a team of researchers led by Shahriar Mobashery at the University of Notre Dame have found a possible way to treat…